VivoSeq
Other

MACE

0

Pipeline Programs↗

3

Active Trials↗

5

Companies Involved↗

MACE is an early-stage landscape with 0 programs across 5 companies. The most active players are Torrent Pharmaceuticals Limited, NeuroGenetic Pharmaceuticals Inc, Sun Pharmaceutical Industries Limited.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

92/100

Attrition Rate

5/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

T

Torrent Pharmaceuticals Limited

0 programs

PreclinicalN

NeuroGenetic Pharmaceuticals Inc

0 programs

PreclinicalSun Pharmaceutical Industries Limited logo

Sun Pharmaceutical Industries Limited

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalChiesi Farmaceutici S.p.A. logo

Chiesi Farmaceutici S.p.A.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

59

clinical trials

Completed49 · 83%
Terminated3 · 5%
Unknown status3 · 5%
Active, not recruiting2 · 3%
Suspended1 · 2%
Recruiting1 · 2%

Clinical Trials

Trial Activity

59 trials

Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)
Recruiting·—·Phase 1·NCT06943495·60 enrolled
Radiopharmaceuticals Analysis for Detailed Insights And INternational Tracking of Safety
Active, not recruiting·UUniversity Hospital, Caen·N/A·NCT06483685·500,000 enrolled
Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS
Active, not recruiting·UUniversity of Colorado, Denver·Phase 1/2·NCT03564873·28 enrolled
Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Topiramate Tablets Under Fed Conditions
Completed·TTorrent Pharmaceuticals Limited·Phase 1·NCT00939705·18 enrolled
Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition
Completed·TTorrent Pharmaceuticals Limited·Phase 1·NCT00940238
Bioequivalence Study of Torrent Pharmaceutical Limited's Pantoprazole Sodium 40 mg Delayed Release Tablets Under Fed Conditions
Completed·TTorrent Pharmaceuticals Limited·Phase 1·NCT01418443
Bioequivalence Study of Daclatasvir From Daclatasvir Zeta 60 mg Film Coated Tablets (Zeta Pharm Pharmaceutical Industries, Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)
Completed·GGenuine Research Center, Egypt·Phase 1·NCT02756936·24 enrolled
Bioequivalence Study of Vonoprazan From Topoprazan 20 mg Tablets (Hikma Pharma, Egypt) Versus Takecab 20 mg Tablets (Takeda Pharmaceutical Co. Ltd., Japan)
Completed·GGenuine Research Center, Egypt·Phase 1·NCT05135793·29 enrolled
Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions
Completed·TTorrent Pharmaceuticals Limited·Phase 1·NCT01418612
Bioequivalence Study of Mirabegron From Bladogra 25 mg Extended Release Tablets (Multi-Apex for Pharmaceutical Industries, Egypt) Versus Myrbetriq 25 mg Extended Release Tablets (Marketed by Astellas Pharma US, Inc, Product of Japan)
Completed·GGenuine Research Center, Egypt·Phase 1·NCT04476966·29 enrolled
Bioequivalence Study of Torrent Pharmaceutical Limited's Isosorbide Mononitrate 120 mg ER Tablets Under Fed Conditions
Completed·TTorrent Pharmaceuticals Limited·Phase 1·NCT01418547
Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)
Completed·NNeuroGenetic Pharmaceuticals Inc·Phase 1·NCT02537938·24 enrolled
Bioequivalence Study of Torrent Pharmaceutical Ltd's Esomeprazole Magnesium Delayed Release Capsules
Completed·TTorrent Pharmaceuticals Limited·Phase 1·NCT02680132·56 enrolled
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Alfuzosin ER Tablets Under Fasted Conditions
Completed·TTorrent Pharmaceuticals Limited·Phase 1·NCT01418586
A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)
Completed·Sun Pharmaceutical Industries Limited logoSun Pharmaceutical Industries Limited·Phase 3·NCT03528577·128 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)